Skip to content
healthcare.dev

Myalept

NDC 10122-210, metreleptin, injection, powder, lyophilized, for solution, from Chiesi USA, Inc..

Product NDC
10122-210
Status
Listed
Labeler
Chiesi USA, Inc.
Dosage form
INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Route
SUBCUTANEOUS
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
BLA
Application
BLA125390
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/10122-210 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • METRELEPTIN11.3 mg/2.2mL

Pharmacologic classes

Analogs/Derivatives [Chemical/Ingredient]; Leptin Analog [EPC]; Leptin [Chemical/Ingredient]

Package NDCNDC-11Package
10122-210-02101220210021 VIAL, GLASS in 1 CARTON (10122-210-02) / 2.2 mL in 1 VIAL, GLASS

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/d3b50bbd-140b-425c-b5ec-d4682aad62bc

Use it

Look up 10122-210 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/10122-210 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 10122-210. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.